Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults
NCT ID: NCT03065309
Last Updated: 2017-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
15 participants
INTERVENTIONAL
2017-02-25
2017-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Rocuronium Onset Time According to Remifentanil Infusion
NCT01030510
Mean Arterial Pressure Reduction Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion
NCT04291794
The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients
NCT01720498
Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index
NCT02890186
Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room
NCT06733129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Remifentanil a potent opioid associated to bradycardia and hypotension at high doses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
Patients will receive bolus dose of remifentanil before intubation
Remifentanil
bolus dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remifentanil
bolus dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Monitoring problems
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brasilia University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gabriel Magalhaes Nunes Guimaraes
Head of Anesthesia department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabriel MN Guimarães, MSc
Role: STUDY_DIRECTOR
Head of Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital das Forças Armadas
Brasília, Federal District, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TCC-Lara-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.